Gliclazid Stada Arzneimittel Ag

Gliclazide is an oral medication used to manage blood sugar levels in adults with type 2 diabetes. This antidiabetic agent helps control glucose by stimulating insulin release from the pancreas.

Gliclazide is primarily used to treat type 2 diabetes by lowering blood sugar levels. It works by increasing insulin secretion from the pancreas, which helps the body use glucose more effectively. This medication is often prescribed as part of a broader diabetes management plan, which may include diet and exercise.

Common effects of Gliclazide may include mild hypoglycemia, nausea, and digestive discomfort. Some users may experience dizziness or headaches. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Gliclazide should be handled with care, especially by individuals with a history of liver or kidney issues. It is important to follow the prescribed dosage and monitor blood sugar levels regularly. Always consult a healthcare provider before starting or stopping this medication.

Gliclazide may interact with other medications, including certain antibiotics, antifungal drugs, and other diabetes medications. Alcohol consumption should be avoided as it can enhance the hypoglycemic effects. Always inform your healthcare provider about all medications you are taking.